A Pilot Study to Investigate the Safety and Clinical Activity of Avelumab (MSB0010718C) in Thymoma and Thymic Carcinoma After Progression on Platinum-Based Chemotherapy
Clinical trial NCT03076554 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT03076554
- Sponsor
- National Cancer Institute (NCI)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-04-19
- Primary completion
- 2027-03-30
- Enrollment
- 56
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.